Cervical cancer screening Cancer Malignant neoplasm of cervix uteri
Conditions
Interventions
The primary observational component is assessing anxiety and beliefs about HPV in women testing positive for HPV with normal cytology within 2 weeks of receiving their test result. It is a cross-secti
Sponsors
University College London (UCL)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women aged 24-65 who have tested positive for HPV with normal cytology within the last 2 weeks at NHSCSP HPV primary screening
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For the observational component: State anxiety and anxiety specific to cervical screening, measured using the State Trait Anxiety Inventory (S-STAI-6) and Cervical Screening Questionnaire (CSQ), respectively For the interventional component: Participation response rate All outcomes measured at one timepoint only | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Illness beliefs measured using B-IPQ 2. Symptom perception measured using adapted IPQ-R 3. Coping style measured using adapted Brief COPE 4. Concerns about HPV, disclosure of results, intention to re-attend screening, barriers to screening re-attendance, all measured using questions developed for the study 5. Prospective 12-month screening attendance, measured using clinical records 6. Demographics including: ethnicity, marital status, and highest level of education (all self-report) 7. Age, index of multiple deprivation score, number of previous cervical screens, and NHS site, collected via clinical records 8. Self-reported history of anxiety or depression All outcomes with the exception of prospective 12-month cervical screening attendance measured at one timepoint only | — |
Countries
England, United Kingdom
Contacts
Public ContactEmily McBride
Outcome results
None listed